Future work needed to advance this field further should focus on investigating if GR expression correlates with GR signaling by analyzing downstream pathways in different subtypes of breast cancer, especially receptor-tyrosine-kinase-like orphan receptor 1 (ROR1) signaling, which has been shown to be associated with aggressive disease and decreased survival in breast cancer [11,38]. The gene discussed is NR3C1; the disease is breast carcinoma.